{"id":3045,"date":"2013-05-06T22:17:00","date_gmt":"2013-05-06T22:17:00","guid":{"rendered":"https:\/\/cdafound.org\/?p=3045"},"modified":"2025-01-16T19:32:52","modified_gmt":"2025-01-16T19:32:52","slug":"chronic-hepatitis-c-virus-hcv-disease-burden-and-cost-in-the-united-states","status":"publish","type":"post","link":"https:\/\/cdafound.org\/fr\/chronic-hepatitis-c-virus-hcv-disease-burden-and-cost-in-the-united-states\/","title":{"rendered":"Fardeau et co\u00fbt de la maladie du virus de l&#039;h\u00e9patite C chronique (VHC) aux \u00c9tats-Unis"},"content":{"rendered":"<h2 class=\"wp-block-heading\">R\u00e9sum\u00e9<\/h2>\n\n\n\n<p>L&#039;infection par le virus de l&#039;h\u00e9patite C (VHC) est l&#039;une des principales causes de cirrhose, de carcinome h\u00e9patocellulaire et de transplantation h\u00e9patique. Une meilleure compr\u00e9hension de la progression de la maladie du VHC et du co\u00fbt associ\u00e9 peut aider la communaut\u00e9 m\u00e9dicale \u00e0 g\u00e9rer le VHC et \u00e0 d\u00e9velopper des strat\u00e9gies de traitement \u00e0 la lumi\u00e8re de l&#039;\u00e9mergence de plusieurs th\u00e9rapies anti-VHC puissantes. Un mod\u00e8le dynamique de syst\u00e8me avec 36 cohortes a \u00e9t\u00e9 utilis\u00e9 pour offrir une flexibilit\u00e9 maximale et une meilleure pr\u00e9vision. L&#039;incidence des nouvelles infections de 16 020 (intervalle de confiance 95%, 13 510-19 510) a \u00e9t\u00e9 estim\u00e9e en 2010. La pr\u00e9valence vir\u00e9mique du VHC a culmin\u00e9 en 1994 \u00e0 3,3 (2,8-4,0) millions, mais elle devrait diminuer des deux tiers d&#039;ici 2030. on s&#039;attend cependant \u00e0 ce qu&#039;une maladie du foie plus avanc\u00e9e augmente, ainsi que le co\u00fbt total associ\u00e9 \u00e0 l&#039;infection chronique par le VHC. Aujourd&#039;hui, le co\u00fbt total est estim\u00e9 \u00e0 $6,5 ($4,3-$8,4) milliard et il culminera en 2024 \u00e0 $9,1 ($6,4-$13,3) milliard. Le co\u00fbt \u00e0 vie d&#039;une personne infect\u00e9e par le VHC en 2011 a \u00e9t\u00e9 estim\u00e9 \u00e0 $64 490. Cependant, ce co\u00fbt est nettement plus \u00e9lev\u00e9 chez les personnes ayant une esp\u00e9rance de vie plus longue.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Conclusion<\/h3>\n\n\n\n<p>Cette analyse d\u00e9montre que la pr\u00e9valence du VHC aux \u00c9tats-Unis est en baisse en raison d&#039;une moindre incidence des infections. Cependant, la pr\u00e9valence de la maladie h\u00e9patique avanc\u00e9e continuera d&#039;augmenter ainsi que les co\u00fbts de sant\u00e9 correspondants. Les frais de sant\u00e9 \u00e0 vie pour une personne infect\u00e9e par le VHC sont nettement plus \u00e9lev\u00e9s que pour les personnes non infect\u00e9es. De plus, il est possible de r\u00e9duire consid\u00e9rablement l&#039;infection par le VHC gr\u00e2ce \u00e0 une gestion active. (H\u00c9PATOLOGIE 2013; 57: 2164-2170).<\/p>\n\n\n\n<p><strong>Des pays:<\/strong> \u00c9tats Unis<\/p>\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button is-style-outline is-style-outline--1\"><a class=\"wp-block-button__link has-text-color wp-element-button\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23280550\/\" target=\"_blank\" rel=\"noreferrer noopener\">Lire le rapport complet<\/a><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Summary Hepatitis C virus (HCV) infection is a leading cause of cirrhosis, hepatocellular carcinoma, and liver transplantation. A better understanding of HCV disease progression and the associated cost can help the medical community manage HCV and develop treatment strategies in light of the emergence of several potent anti-HCV therapies. A system dynamic model with 36 [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":3479,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[9],"tags":[10],"publication-author":[2392,2393,535,2394,2291,2299,494],"class_list":["post-3045","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publication","tag-hcv","publication-author-elbasha-e","publication-author-elkhoury-ac","publication-author-estes-c","publication-author-kumar-r","publication-author-pasini-k","publication-author-poynard-t","publication-author-razavi-h"],"acf":[],"_links":{"self":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/3045","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/comments?post=3045"}],"version-history":[{"count":5,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/3045\/revisions"}],"predecessor-version":[{"id":7649,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/posts\/3045\/revisions\/7649"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/media\/3479"}],"wp:attachment":[{"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/media?parent=3045"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/categories?post=3045"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/tags?post=3045"},{"taxonomy":"publication-author","embeddable":true,"href":"https:\/\/cdafound.org\/fr\/wp-json\/wp\/v2\/publication-author?post=3045"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}